Header Logo

Connection

ROY F CHEMALY to Respiratory Tract Infections

Back to Details
This is a "connection" page, showing publications ROY F CHEMALY has written about Respiratory Tract Infections.
ROY F CHEMALY
Connection Strength
8.570
Respiratory Tract Infections
  1. Clinical trials for treatment of respiratory viral infections in recipients of haematopoietic cell transplantation and cellular therapies: are we on the right path to the finish line? Clin Microbiol Infect. 2024 Mar; 30(3):270-275.
    View in: PubMed
    Score: 0.686
  2. Predicting risk of progression to lower respiratory tract infection in allogeneic hematopoietic cell transplant recipients with respiratory viral infections: where are we now? Bone Marrow Transplant. 2022 05; 57(5):701-702.
    View in: PubMed
    Score: 0.615
  3. DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled Study. Clin Infect Dis. 2021 08 02; 73(3):e773-e781.
    View in: PubMed
    Score: 0.592
  4. A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients. Clin Infect Dis. 2020 12 31; 71(11):2777-2786.
    View in: PubMed
    Score: 0.568
  5. Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies. Haematologica. 2019 07; 104(7):1322-1331.
    View in: PubMed
    Score: 0.511
  6. Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients. Clin Infect Dis. 2019 05 02; 68(10):1641-1649.
    View in: PubMed
    Score: 0.506
  7. Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection. J Antimicrob Chemother. 2018 11 01; 73(11):3162-3169.
    View in: PubMed
    Score: 0.489
  8. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies. Transpl Infect Dis. 2018 Dec; 20(6):e12994.
    View in: PubMed
    Score: 0.485
  9. Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes. Cancer. 2017 Jun 15; 123(12):2329-2337.
    View in: PubMed
    Score: 0.434
  10. Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert Rev Anti Infect Ther. 2017 04; 15(4):401-415.
    View in: PubMed
    Score: 0.432
  11. Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review. Cancer Lett. 2016 08 28; 379(1):100-6.
    View in: PubMed
    Score: 0.413
  12. Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies. Clin Infect Dis. 2014 Nov 15; 59 Suppl 5:S344-51.
    View in: PubMed
    Score: 0.372
  13. Respiratory syncytial virus infections in children with cancer. J Pediatr Hematol Oncol. 2014 Aug; 36(6):e376-81.
    View in: PubMed
    Score: 0.364
  14. Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections. Blood. 2014 May 22; 123(21):3263-8.
    View in: PubMed
    Score: 0.356
  15. Reply to Robinson. J Infect Dis. 2013 Sep 01; 208(5):864-5.
    View in: PubMed
    Score: 0.337
  16. Reply to F?tkenheuer et al. J Infect Dis. 2013 May 15; 207(10):1622-3.
    View in: PubMed
    Score: 0.330
  17. An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection. J Infect Dis. 2012 Nov; 206(9):1367-71.
    View in: PubMed
    Score: 0.318
  18. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore). 2006 Sep; 85(5):278-287.
    View in: PubMed
    Score: 0.210
  19. Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation. Br J Haematol. 2021 07; 194(1):145-157.
    View in: PubMed
    Score: 0.147
  20. Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant. 2019 04; 25(4):800-809.
    View in: PubMed
    Score: 0.123
  21. Progression of the Radiologic Severity Index predicts mortality in patients with parainfluenza virus-associated lower respiratory infections. PLoS One. 2018; 13(5):e0197418.
    View in: PubMed
    Score: 0.118
  22. Severe parainfluenza virus type 2 supraglottitis in an immunocompetent adult host: an unusual cause of a paramyxoviridae viral infection. J Intern Med. 2009 Mar; 265(3):397-400.
    View in: PubMed
    Score: 0.061
  23. Common community respiratory viruses in patients with cancer: more than just "common colds". Cancer. 2003 May 15; 97(10):2576-87.
    View in: PubMed
    Score: 0.042
  24. Refinement of estimates of mortality risk using the Radiologic Severity Index in hematologic malignancy patients with respiratory syncytial virus infection. Transpl Infect Dis. 2019 Aug; 21(4):e13105.
    View in: PubMed
    Score: 0.032
  25. Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers. J Med Virol. 2018 01; 90(1):50-60.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.